Quantitative Systems Pharmacology: A Framework for Context
- PMID: 27570730
- PMCID: PMC4996481
- DOI: 10.1007/s40495-016-0058-x
Quantitative Systems Pharmacology: A Framework for Context
Abstract
Quantitative Systems Pharmacology (QSP) is receiving increased attention. As the momentum builds and the expectations grow it is important to (re)assess and formalize the basic concepts and approaches. In this short review, I argue that QSP, in addition to enabling the rational integration of data and development of complex models, maybe more importantly, provides the foundations for developing an integrated framework for the assessment of drugs and their impact on disease within a broader context expanding the envelope to account in great detail for physiology, environment and prior history. I articulate some of the critical enablers, major obstacles and exciting opportunities manifesting themselves along the way. Charting such overarching themes will enable practitioners to identify major and defining factors as the field progressively moves towards personalized and precision health care delivery.
Keywords: PKPD; chronic disease; inflammation; quantitative systems pharmacology.
Similar articles
-
Towards a comprehensive assessment of QSP models: what would it take?J Pharmacokinet Pharmacodyn. 2024 Oct;51(5):521-531. doi: 10.1007/s10928-022-09820-0. Epub 2022 Aug 13. J Pharmacokinet Pharmacodyn. 2024. PMID: 35962928 Free PMC article. Review.
-
Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.AAPS J. 2019 Jun 3;21(4):72. doi: 10.1208/s12248-019-0339-5. AAPS J. 2019. PMID: 31161268 Review.
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
Towards personalized treatment of pain using a quantitative systems pharmacology approach.Eur J Pharm Sci. 2017 Nov 15;109S:S32-S38. doi: 10.1016/j.ejps.2017.05.027. Epub 2017 May 12. Eur J Pharm Sci. 2017. PMID: 28506867 Review.
-
Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network.CPT Pharmacometrics Syst Pharmacol. 2019 May;8(5):259-272. doi: 10.1002/psp4.12381. Epub 2019 Mar 22. CPT Pharmacometrics Syst Pharmacol. 2019. PMID: 30667172 Free PMC article.
Cited by
-
Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.AAPS J. 2020 Jul 27;22(5):97. doi: 10.1208/s12248-020-00470-z. AAPS J. 2020. PMID: 32719954
-
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region.Saudi Pharm J. 2024 Dec;32(12):102207. doi: 10.1016/j.jsps.2024.102207. Epub 2024 Nov 27. Saudi Pharm J. 2024. PMID: 39697476 Free PMC article. Review.
-
Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits.PLoS One. 2018 Mar 21;13(3):e0194294. doi: 10.1371/journal.pone.0194294. eCollection 2018. PLoS One. 2018. PMID: 29561908 Free PMC article.
-
From data to QSP models: a pipeline for using Boolean networks for hypothesis inference and dynamic model building.J Pharmacokinet Pharmacodyn. 2022 Feb;49(1):101-115. doi: 10.1007/s10928-021-09797-2. Epub 2022 Jan 6. J Pharmacokinet Pharmacodyn. 2022. PMID: 34988912 Free PMC article.
-
The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach.J Pharm Sci. 2024 Jan;113(1):33-46. doi: 10.1016/j.xphs.2023.08.005. Epub 2023 Aug 18. J Pharm Sci. 2024. PMID: 37597751 Free PMC article. Review.
References
-
- Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90(5):2522–30. doi:10.1210/jc.2004-1667. - PubMed
-
- Allan G, Davis J, Dickins M, Gardner I, Jenkins T, Jones H, et al. Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man. Xenobiotica. 2008;38(6):620–40. doi:10.1080/00498250802069088. - PubMed
-
- Androulakis IP. Systems engineering meets quantitative systems pharmacology: from low-level targets to engaging the host defenses. Wiley Interdiscip Rev Syst Biol Med. 2015;7(3):101–12. doi:10.1002/wsbm.1294. - PubMed
-
- Androulakis IP, Kamisoglu K, Mattick JS. Topology and dynamics of signaling networks: in search of transcriptional control of the inflammatory response. Annu Rev Biomed Eng. 2013;15:1–28. doi:10.1146/annurev-bioeng-071812-152425. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials